P3.01-075 Afatinib Dose Adjustment: Effect on Safety, Efficacy and Patient-Reported Outcomes in the LUX-Lung 3/6 Trials in EGFRm+ NSCLC

Vera Hirsh, J.C-H. Yang, Yun Wu et al.|Journal of Thoracic Oncology|2017

Cited by 0